HERM ROSENMAN - 16 Feb 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
Director
Signature
/s/ Tami Chen, Attorney-in-Fact
Issuer symbol
NTRA
Transactions as of
16 Feb 2024
Net transactions value
-$6,264,886
Form type
4
Filing time
16 Feb 2024, 21:45:08 UTC
Previous filing
30 Jan 2024
Next filing
30 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise $249,486 +93,901 +152% $2.66* 155,586 16 Feb 2024 Direct
transaction NTRA Common Stock Sale $4,003,520 -57,954 -37% $69.08 97,632 16 Feb 2024 Direct F1, F2
transaction NTRA Common Stock Sale $2,510,851 -35,947 -37% $69.85 61,685 16 Feb 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -93,901 -100% $0.000000* 0 16 Feb 2024 Common Stock 93,901 $2.66 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.5270 to $69.36 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.53 to $70.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The Reporting Person exercised this option as required prior to the expiration date of February 24, 2024.
F5 The option shares are fully exercisable.